WARNING: LIFE-THREATENING RESPIRATORY DEPRESSION and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS
Life-Threatening Respiratory Depression
...
Did you find an answer to your question?
Yes
No
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Our medical information is accurate, up to date, and scientifically balanced.
nalbuphine hydrochloride injection
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Our medical information is accurate, up to date, and scientifically balanced.
nalbuphine hydrochloride injection Quick Finder
Indications and Usage
INDICATIONS AND USAGE
Nalbuphine Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Nalbuphine Hydrochloride...
Did you find an answer to your question?
Yes
No
Dosage and Administration
DOSAGE AND ADMINISTRATION
Important Dosage and Administration Instructions
Nalbuphine Hydrochloride Injection should be administered as a...
Did you find an answer to your question?
Yes
No
Warnings and Precautions
WARNINGS
Life-Threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression has been reported with the use of opioids, even when used...
Did you find an answer to your question?
Yes
No
Adverse Reactions
ADVERSE REACTIONS
The most frequent adverse reaction in 1066 patients treated in clinical studies with Nalbuphine Hydrochloride Injection was sedation 381 (36%).
Less frequent reactions were: sweaty/clammy 99 (9%),...
Did you find an answer to your question?
Yes
No
Drug Abuse and Dependence
DRUG ABUSE AND DEPENDENCE
Abuse
Nalbuphine Hydrochloride Injection contains nalbuphine, which can be abused and is subject to misuse, addiction, and criminal diversion...
Did you find an answer to your question?
Yes
No
Overdosage
OVERDOSAGE
Clinical Presentation
Acute overdose with Nalbuphine Hydrochloride Injection alone can be manifested by respiratory depression and dysphoria. Acute overdose...
Did you find an answer to your question?
Yes
No
Description
DESCRIPTION
Nalbuphine hydrochloride is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. It is chemically related to both the widely used opioid antagonist, naloxone, and the potent opioid analgesic...
Did you find an answer to your question?
Yes
No
Clinical Pharmacology
...
CLINICAL PHARMACOLOGY
Mechanism of Action
Nalbuphine is an agonist at kappa opioid receptors and an antagonist at mµ opioid receptors.
Did you find an answer to your question?
Yes
No
How Supplied/Storage and Handling
HOW SUPPLIED
Nalbuphine Hydrochloride Injection for intramuscular, subcutaneous, or intravenous use is a sterile solution available in:
Did you find an answer to your question?
Yes
No
...
Did you find an answer to your question?
Yes
No
Didn’t find what you were looking for? Contact us.
To interact with the Medical Information Digital Assistant click here.
Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985
Report Adverse Event
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at(800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.
(800)-332-1088.